Tanner, Georgette
Barrow, Rhiannon
Ajaib, Shoaib
Al-Jabri, Muna
Ahmed, Nazia
Pollock, Steven
Finetti, Martina
Rippaus, Nora
Bruns, Alexander F.
Syed, Khaja
Poulter, James A.
Matthews, Laura
Hughes, Thomas
Wilson, Erica
Johnson, Colin
Varn, Frederick S.
Brüning-Richardson, Anke
Hogg, Catherine
Droop, Alastair
Gusnanto, Arief
Care, Matthew A.
Cutillo, Luisa
Westhead, David R.
Short, Susan C.
Jenkinson, Michael D.
Brodbelt, Andrew
Chakrabarty, Aruna
Ismail, Azzam
Verhaak, Roel G. W.
Stead, Lucy F. http://orcid.org/0000-0002-9550-4150
Funding for this research was provided by:
UK Research and Innovation (MR/T020504/1)
Leeds Hospitals Charity (9R11/14‐11)
Brain Research UK (PhD Studentship)
Yorkshire's Brain Tumour Charity (LeedsNeuroRTB)
OSCARs Paediatric Brain Tumour Charity (LeedsNeuroRTB)
Article History
Received: 3 February 2023
Accepted: 11 January 2024
First Online: 7 February 2024
Declarations
:
: All samples were from patients who provided informed, written consent. The use of consented samples was following favorable opinion of a project-specific application by NHS Health Research Authority: South Central—Oxford A Research Ethics Committee (reference 13/SC/0509).
: RGWV is a consultant for NeuroTrials, Inc, and Stellanova Therapeutics. AD is the director of AD Bioinformatics Ltd. LFS is on the Scientific Advisory Board for CoSyne Therapeutics Ltd.